SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $126,000 | -51.7% | 74,216 | -50.5% | 0.01% | -33.3% |
| Q2 2018 | $261,000 | +455.3% | 149,969 | +480.7% | 0.01% | +300.0% |
| Q1 2018 | $47,000 | -87.9% | 25,827 | -85.1% | 0.00% | -85.7% |
| Q4 2017 | $387,000 | +360.7% | 173,704 | +500.3% | 0.02% | +425.0% |
| Q3 2017 | $84,000 | +58.5% | 28,936 | +144.6% | 0.00% | -42.9% |
| Q2 2017 | $53,000 | – | 11,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |